Latest Articles

FT LEX – Zurich: bland ambition

FT LEX – Zurich: bland ambition

Simplicity may be a virtue to new Zurich Insurance boss Mario Greco; ambition certainly is not. On Thursday the CEO, who joined from Generali in March, branded ... »

Novartis’ ‘breakthrough’ muscle drug bimagrumab flunks a late-stage trial

Novartis’ ‘breakthrough’ muscle drug bimagrumab flunks a late-stage trial

Novartis ($NVS) buried some bad pipeline news in its quarterly report today. The pharma giant says that its “breakthrough” drug bimagrumab (BYM338) failed a Pha... »

SIX Swiss Exchange wins “Exchange of the Year” award at the Structured Products Awards Europe 2016.

SIX Swiss Exchange wins “Exchange of the Year” award at the Structured Products Awards Europe 2016.

The Structured Products Europe awards have an excellent reputation in the industry. They were introduced to recognize the best European financial service provid... »

Novartis Is Struggling To Compete

Novartis Is Struggling To Compete

Nov. 2, 2015 Summary: Novartis has seen its operations deteriorate in recent years. Both margins and top-line growth have contracted in 2015. With rising compet... »

Swiss Exchange – Morning / Evening Report

Swiss Exchange – Morning / Evening Report

Daily market preview and market wrap up from a leading swiss finance newspaper "Finanz & Wirtschaft" (in German) »

Featured Articles

crucif AI – Artificial Intelligence for detecting ethical deficits and dysfunctional behavior

crucif AI – Artificial Intelligence for detecting ethical deficits and dysfunctional behavior

WHISTLE-BLOWING:  A civic duty

WHISTLE-BLOWING: A civic duty

Enhanced Corporate Governance through Independent Oversight

Enhanced Corporate Governance through Independent Oversight

Culinary Corner

Culinary Corner